Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03857919 · ClinicalTrials.gov registry record · NA
TearCare System to Treat Dry Eye Disease
A NA study, sponsored by Sight Sciences.
- Completed
- Registry status
- NA
- Development phase
- 235
- Enrollment target
NCT03857919 is a NA study that has completed, run by Sight Sciences. The registered enrollment target is 235 participants.
The verdict
NCT03857919, a NA study, has completed, sponsored by Sight Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 235 participants
- Enrollment target
Study Summary
In this study, the TearCare System will be compared with the LipiFlow Thermal Pulsation System in patients with dry eye disease. The objective is to demonstrate that the TearCare System is safe and effective in relieving the signs and symptoms of dry eye disease.
Interventions
- DEVICE TearCare
- DEVICE LipiFlow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2019-03-03 |
| Est. Completion | 2020-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03857919
The ClinicalTrials.gov registry entry for NCT03857919 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 235 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sight Sciences, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TearCare is the first listed.
NCT03857919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03857919 about?
NCT03857919 is a clinical study titled "TearCare System to Treat Dry Eye Disease". In this study, the TearCare System will be compared with the LipiFlow Thermal Pulsation System in patients with dry eye disease. The objective is to demonstrate that the TearCare System is safe and effective in relieving the signs and symptoms of dry eye disease.
What is the current status of trial NCT03857919?
This trial is currently completed. It is a NA study. The enrollment target is 235 participants. The study started on 2019-03-03. Estimated completion is 2020-12-18.
What interventions are being tested in trial NCT03857919?
The interventions under investigation include: TearCare (DEVICE), LipiFlow (DEVICE).
Who is sponsoring clinical trial NCT03857919?
This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.